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Presenilin-Mediated Modulation
of Capacitative Calcium Entry
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molecular phenotypes of FAD-associated mutations in
the presenilins include increased levels of the 42 aminoSummary
acid version of Ab (Ab42) in AD patients (Scheuner et
al., 1996) as well as transfected cell lines and transgenicWe studied a novel function of the presenilins (PS1 and
animals expressing FAD mutant forms of PS1 or PS2PS2) in governing capacitative calcium entry (CCE), a
(Borchelt et al., 1996; Citron et al., 1996; Duff et al., 1996;refilling mechanism for depleted intracellular calcium
Tomita et al., 1997; Oyama et al., 1998). Ab42 is an initialstores. Abrogation of functional PS1, by either knock-
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(FAD)–linked mutant PS1 or PS2 significantly attenu- ing FAD mutant presenilins also exhibit altered cellular
ated CCE and store depletion–activated currents. properties in relation to intracellular Ca21 homeostasis.
While inhibition of CCE selectively increased the amy- One of the most consistent effects of presenilin FAD
loidogenic amyloid b peptide (Ab42), increased accu- mutations on Ca21 signaling is the potentiation of IP3-
mulation of the peptide had no effect on CCE. Thus, mediated release of Ca21 from the internal store (Ito et
reduced CCE is most likely an early cellular event lead- al., 1994; Gibson et al., 1996; Guo et al., 1996; Etcheberri-
ing to increased Ab42 generation associated with FAD garay et al., 1998; Leissring et al., 1999). However, the
mutant presenilins. Our data indicate that the CCE exact contribution of the presenilins on the intracellu-
pathway is a novel therapeutic target for Alzheimer’s lar Ca21 signaling pathway has never been fully eluci-
disease. dated. Moreover, a molecular connection between this
Ca21-related phenotype and other presenilin FAD pheno-
Introduction types, such as increased Ab42 generation, remains un-
resolved. Since the Ab42-promoting effect of FAD mu-
tant presenilins does not appear to be cell type specificInherited mutations in the genes encoding the homolo-
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and pathological functions of presenilins on a commonPS2 are polytopic membrane proteins containing eight
Ca21 regulatory pathway in both electrically excitableputative transmembrane (TM) domains (Doan et al.,
and nonexcitable cells (Grudt et al., 1996; Bouron, 2000).1996; Li and Greenwald, 1998) and localized to intracel-
The process of IP3-mediated Ca21 release from the en-lular membranes (Cook et al., 1996; Kovacs et al., 1996;
doplasmic reticulum (ER) store and replenishing intra-Kim et al., 2000). Although a majority of nascent full-
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Figure 1. PS1 Deficiency Potentiates the CCE
Response
(A) Cultured cortical neurons from day 15.5
embryos from heterozygote (1/2, control 1),
homozygote (1/1, control 2), or knockout
(2/2) mice were subjected to Western blot-
ting using aPS1Loop antibody.
(B) Potentiation of CCE in PS1-deficient neu-
rons (PS1 2/2) as compared to control 1
(1/2) or control 2 (1/1). Data points are
mean fluorescence ratios 6 SEM in 27–34
cells (*p , 0.0001, compared to controls).
CCE was induced by incubating cells with
Ca21-free media containing 2 mM cyclo-
piazonic acid (CPA) for 30 min and then wash-
ing the cells with Ca21-free HBSS (0 mM
[Ca21]o; see Experimental Procedures) and re-
placing Ca21-free buffer with Ca21-containing
media (1.8 mM [Ca21]o).
membrane CCE channels (Irvine, 1990; Berridge, 1995; incubated in Ca21-free media containing an ER Ca21-
depleting reagent, such as cyclopiazonic acid (CPA),Patterson et al., 1999; Yao et al., 1999; Ma et al., 2000).
Here, we show that either elimination of PS1 or expres- and then washed and replenished with Ca21-containing
media (Patterson et al., 1999; Yoo et al., 1999). CCE wassion of inactive PS1 mutants hyperactivates CCE, indi-
cating that functional presenilin is normally required for then monitored by ratiometric imaging using fura-2/AM
(Figure 1B). A dramatic increase in CCE was observed inthe proper modulation of CCE. Furthermore, FAD-asso-
ciated mutations in both PS1 and PS2 universally down- PS1-deficient neurons as compared to control neurons
(Figure 1B); this result indicates that CCE is greatly po-regulate CCE in multiple cell types, including neurons.
Electrophysiological studies also confirm that CCE tentiated by the absence of PS1, suggesting that PS1
may normally be necessary to regulate CCE.channel activity is dramatically diminished by a prese-
nilin FAD mutation. Moreover, we have delineated the
temporal order of two separate molecular phenotypes Biologically Active PS1 Is Required
for CCE Modulationassociated with presenilin FAD: Ca21 dyshomeostasis
and Ab42-promoting activity. Our studies indicate that To further define the mechanism underlying the en-
hanced CCE in PS1-deficient neurons, we next exam-reduced CCE is likely to be an upstream event for the
increased generation of Ab42. Given the putative mech- ined the effect of abrogation of PS1 biological activities
on CCE. For this purpose, we established SY5Y cell linesanism of CCE, our studies suggest that the presenilins
modulate the coupling between the ER Ca21 stores and stably expressing PS1 variant containing a TM aspartate
mutation that was shown to abrogate the biological ac-the plasma membrane. This activity may be critical for
the modulation of CCE and the proteolytic processing tivities of PS1 (D257A-PS1) (Figure 2A). In these cells,
the impaired endoproteolytic processing of PS1 resultedof membrane proteins, such as APP.
in the accumulation of full-length PS1 holoprotein (Wolfe
et al., 1999), which largely replaced the endogenousResults
PS1 C-terminal fragment (Figure 2A). We also observed
an increased accumulation of putative g-secretase sub-PS1 Deficiency Enhances CCE Response
Given the previously reported link between PS1 FAD strate, the endogenous APP C-terminal fragments (APP-
CT83) (Figure 2B), although the increase was not asmutations and Ca21 dyshomeostasis, we set out to in-
vestigate the possibility that a normal function of PS1 robust as in a previous study utilizing APP-overexpress-
ing cells (Wolfe et al., 1999; Kimberly et al., 2000). Inter-involves the modulation of CCE. To this end, we studied
the effects of PS1 deficiency on CCE utilizing cultured estingly, CCE was enhanced by z125% in D257A-PS1
cells as compared to wild-type PS1 SY5Y cells (Figuresprimary neurons derived from PS1 knockout mice. Corti-
cal neuronal cultures were prepared from day 15.5 em- 2C and 2D). CCE was also potentiated by two separate
TM aspartate mutations (D257A and D385A) in stablebryos of either heterozygote PS1 1/2, homozygote PS1
1/1, or PS1 2/2 mice (Shen et al., 1997). PS1 deficiency CHO cell lines (Figure 2E). These data reveal that mutat-
ing the TM aspartate residues, both of which have beenin PS1 2/2 neurons was verified by Western blot analy-
ses (Figure 1A). To induce CCE artificially, cells were shown to abolish the biological activities of PS1, dramat-
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Figure 2. “Loss-of-Function” Transmembrane Aspartate PS1 Mutations Potentiate the CCE Response
(A) Detergent lysates prepared from SY5Y cells stably transfected with vector (C), wild-type PS1 (WT), FAD mutant PS1 (M146L), or D257A-
PS1 (D257A) were analyzed by Western blot analyses using aPS1Loop antibody. Arrows denote full-length PS1 (FL) and endoproteolytic PS1
C-terminal fragments (PS1-CTF).
(B) A blot identical to (A) was probed with anti-APP antibody (C7) to detect APP holoprotein (APP-FL) and an endogenous APP C-terminal
fragment (APP-CT83).
(C) Potentiation of CCE in SY5Y cells stably expressing D257A-PS1. Data points are mean fluorescence ratios 6 SEM in 30 cells.
(D) Mean peak fluorescence amplitudes were calculated from three independent CCE induction experiments using SY5Y cells expressing
wild-type PS1 (WT) or D257A-PS1 (D257A). Columns are mean peak amplitudes 6 SD, shown as percent of control (*p , 0.0001, as compared
to WT).
(E) Mean peak fluorescence amplitudes were calculated from two independent CCE induction experiments using four different clonal CHO
cell lines expressing wild-type PS1 (WT1 and WT2), D257A-PS1 (D257A), or D385A-PS1 (D385A). Columns are mean peak amplitudes 6 SD,
shown as percent of control (*p , 0.0001, as compared to WT2; **p , 0.0001, as compared to WT1).
ically potentiates CCE. These findings indicate that func- levels of PS protein had no detectable effect on the CCE
tional PS1 is required for the modulation of CCE. response (data not shown). Although CCE potentiation
by the TM aspartate mutation was much greater in SY5Y
cell lines (z125%) as compared to CHO cell lines (z40%)Effects of Presenilin FAD Mutations on CCE
(Figures 2D and 2E), the M146L-PS1 mutation affectedin Stable Transfectants
CCE to a similar degree in both SY5Y and CHO cellsWe next asked whether autosomal dominant presenilin
(Figures 3B and 3C).FAD mutations would potentially render any constitutive
To determine whether a PS2 FAD mutation would elicit“gain-of-function” effects on CCE modulation. To exam-
a similar effect on CCE, we established stable SY5Y celline the effect of a PS1 FAD mutation on CCE, we first
lines expressing either wild-type or the Volga Germanutilized SY5Y cells stably transfected with the M146L-
FAD mutant (N141I) form of PS2 (Figure 3D). In bothPS1 FAD mutant (Figure 2A). When CCE was induced,
native and vector-transfected SY5Y cells, PS2 was virtu-the amplitude of the CCE response was markedly re-
ally undetectable in Western blots of straight lysate (Fig-duced in the M146L-PS1 cells (z42.5% reduction) as
ure 3D; data not shown for native SY5Y cells), indicatingcompared to wild-type PS1- or vector-transfected cells
that detectable PS2 represents the transgene-derived(Figures 3A and 3B). In addition to SY5Y cells, CCE
protein variants in these stable cells. PS2 was detectedwas also found to be attenuated in CHO cells stably
mainly as endoproteolytic fragments in these cells, whileexpressing M146L-PS1 as compared to wild-type PS1
full-length PS2 protein was detectable only after lengthy(Figure 3C). To verify that this attenuation of the CCE
exposures (Figure 3D). As expected, transgene-derivedresponse was not simply due to the elevated levels of
PS2-CTF “replaced” endogenous PS1-CTF (Figure 3D)PS protein in our cell lines, we also measured CCE in
(Thinakaran et al., 1997). When CCE was induced, Ca21wild-type or mutant SY5Y cells as well as CHO cells
with higher PS expression levels; we found that varying influx was dramatically reduced in cells expressing
Neuron
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Figure 3. FAD Mutant Presenilins Attenuate CCE
(A) Effect of the M146L PS1 FAD mutation on CCE in stable SY5Y cell lines. CCE was measured by ratiometric imaging in fura-2-loaded SY5Y
cells stably transfected with vector, wild-type PS1 (WT), or mutant PS1 (M146L) (n 5 26).
(B) Mean peak fluorescence amplitudes were calculated from three independent CCE-induction experiments, using SY5Y cells expressing
vector, wild-type PS1 (WT), and mutant PS1 (M146L) (*p , 0.0001, compared to WT).
(C) Effect of the M146L PS1 FAD mutation on CCE in stable CHO cell lines. Mean peak fluorescence amplitudes were calculated from four
independent CCE induction experiments, using CHO cells stably expressing wild-type PS1 (WT) and mutant PS1 (M146L) (*p , 0.0001,
compared to WT). In each case, the wild-type and PS1-M146L clonal lines were paired for similar levels of expression.
Data points are mean fluorescence ratios (340 nm/380 nm) 6 SEM (A), and columns are mean percent increases 6 SD (B and C).
(D) Lysates prepared from stable SY5Y cell lines expressing vector (C) and either wild-type (WT) or FAD mutant (N141I) forms of PS2 were
analyzed by Western blotting using the PS2 and PS1 antibodies indicated. Locations of full-length PS2 (FL) and C-terminal fragments of PS2
(PS2-CTF) and PS1 (PS1-CTF) are indicated by arrows.
(E) Effect of the N141I PS2 FAD mutation on CCE in stable SY5Y cell lines. CCE was measured by ratiometric imaging in fura-2-loaded SY5Y
cells stably transfected with vector, wild-type PS2 (WT), or mutant PS2 (N141I). Representative data from five independent experiments are
shown (n 5 33).
(F) Mean peak fluorescence amplitudes were calculated from five separate CCE induction experiments, using SY5Y cells expressing vector,
wild-type PS2 (WT), and N141I-PS2 (N141I) (*p , 0.0001, compared to WT).
N141I-PS2 as compared to either wild-type PS2 or vec- coding either wild-type or N141I FAD mutant forms of
PS2. As a source for these primary neuronal cultures,tor alone (Figure 3E). Multiple experiments were aver-
aged to determine the mean peak amplitudes of CCE. we generated transgenic mice expressing wild-type or
N141I FAD mutant forms of human PS2 under the tran-In the N141I-PS2 cells, CCE was reduced by z58.5%
compared to wild-type PS2-transfected cells (Figure scriptional control of the PDGF promoter. The genomic
insertion and expression of human PS2 gene was con-3F). Our results showed that both the M146L PS1 and
N141I PS2 mutations carry a gain of function in overregu- firmed by genotyping of tail DNA and RT-PCR of mRNA
from brain tissues (M. P. F. et al., unpublished data).lating CCE.
To assess the expression of human PS2 protein in
these transgenic animals, brain extracts of heterozy-PS2 FAD Mutation Attenuates CCE in Neurons
from Transgenic Mice gote animals expressing wild-type or N141I PS2 along
with nontransgenic littermates were analyzed by com-We next studied whether FAD mutant presenilin-medi-
ated downregulation of CCE also occurs in neurons. bined immunoprecipitation-Western blot analyses using
aP-S2Loop (Figure 4A). Elevated levels of PS2-CTF wereFor this purpose, we utilized cultured primary neurons
derived from transgenic mice harboring constructs en- observed in groups of transgenic mice expressing hu-
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Figure 4. Primary Cortical Neurons Derived from N141I-PS2 Transgenic Mice Exhibit Attenuated CCE
(A) Characterization of PS2 in transgenic mice. Immunoprecipitation–Western blotting analysis was performed using aPS2Loop in the lysates
prepared from brain tissues of transgenic mice expressing a construct encoding either wild-type (WT-PS2) or N141I FAD mutant (N141I-PS2)
PS2, along with nontransgenic samples (Non-Tg).
(B) Lines with similar levels of protein expression were paired among N and K lines, and protein extracts were analyzed by immunoprecipitation–
Western blotting analysis. A representative blot is shown.
(C) Effects of the N141I-PS2 mutation on CCE in cultured cortical neurons from day 18.5 embryos.
(D) Average mean peak amplitudes were shown as mean fluorescence ratios (340 nm/380 nm) 6 SD (n 5 z50; *p , 0.0001, compared to WT).
man wild-type PS2 and N141I-PS2 transgenes (Figure type animals were similar to those in neurons from non-
transgenic animals (data not shown).4A). In all PS2 founder transgenic mouse lines selected
for the test, no detectable full-length PS2 polypeptides
were observed (data not shown). Founder lines with CCE Inhibitors, but Not L- or N-Type Ca21 Channel
Antagonists or Cytochalasin D, Abolish thesimilar expression levels of PS2-CTF were selected for
breeding and further use (Figure 4B). Effects of FAD Mutant Presenilin on CCE
To further characterize Ca21 influx pathway(s) affectedCortical neuronal cultures were prepared from day
18.5 embryos of either heterozygote wild-type or N141I by presenilin FAD mutations, we studied the effects of
various pharmacological reagents on CCE. The Ca21mutant PS2 animals. Embryos were plated in separate
chambers, and corresponding tissues were removed influx observed in all cell lines was blocked by pretreat-
ment with the CCE inhibitors SKF96365 (Merritt et al.,from each embryo and used for genotyping. In the neu-
ronal cultures, nonneuronal cells were less than z10% 1990; Mason et al., 1993) and Calyculin A (CalyA) (Pat-
terson et al., 1999; Ma et al., 2000) (Figures 5A and 5C).(data not shown), and cell bodies of morphologically
differentiated neurons were selected to conduct Ca21 However, nifedipine and v-conotoxin GVIA, which inhibit
L- and N-type Ca21 channels, respectively, had virtuallyimaging experiments (n 5 z50). CCE was dramatically
suppressed in N141I-PS2 neurons as compared to wild- no effect on Ca21 influx (Figures 5B and 5C). Thus, the
alterations in [Ca21]i were likely CCE specific. In addition,type PS2 neurons (Figure 4C). Three independent Ca21
imaging experiments were performed to determine the CCE reduction in M146L cells was unaffected by
the presence of nifedipine and v-conotoxin GVIA (datamean peak amplitudes, indicating a z50% reduction of
CCE in N141I-PS2 neurons as compared to wild-type not shown), suggesting that the mechanism underlying
reduced CCE in mutant cells is independent of thesePS2 neurons (Figure 4D). Similar to what was observed
in SY5Y cells, the amplitudes of CCE in neurons of wild- types of voltage-operated Ca21 channels. To ensure that
Neuron
566
Figure 5. CCE-Specific Properties of the Observed Ca21 Influx in SY5Y Cell Lines
(A) Inhibition of CCE by SKF96365 or CalyA. SY5Y cells stably expressing wild-type PS2 were pretreated with either 100 mM SKF96365 for 1
hr or 100 nM CalyA for 20 min prior to induction of CCE.
(B) Effects of L-type or N-type voltage-operated Ca21 channel antagonists nifedipine (1 mM) and v-conotoxin GVIA (2 mM), respectively, on
the CCE response in SY5Y cells.
(C) Relative effects of SKF96365, CalyA, v-conotoxin GVIA, nifedipine, and CytoD on CCE in wild-type PS2 cells. Columns are mean peak
amplitudes 6 SD, shown as percent of control.
(D) CytoD has no effect on the observed reduction in CCE caused by the M146L PS1 mutation. Mean peak amplitudes were determined from
three independent experiments using SY5Y cells expressing wild-type PS1 (WT) or mutant PS1 (M146L), either without (Control) or with
(1CytoD) a 2 hr pretreatment of 2 mM CytoD. Columns are mean peak amplitudes in fluorescence ratios 6 SD (*p , 0.0001 and **p , 0.001,
respectively, as compared to WT).
the FAD mutations were actually affecting CCE and not were further investigated by examining ICRAC in wild-type
and M146L-PS1 CHO cells (Figure 6). The time courseother types of Ca21 influx, we tested additional pre-
viously reported properties of CCE. One of the key fea- of activation of ICRAC was determined in single cells fol-
lowed by passive store depletion via patch pipettes con-tures of CCE is its lack of requirement for intact actin
cytoskeleton. For instance, disruption of the intracellular taining Ca21-chelating reagent BAPTA in the whole-cell
configuration, and Na21 was used as the charge carriercytoskeleton by treatment with Cytochalasin D (CytoD)
impairs the IP3-elicited release of Ca21 from internal (Kerschbaum and Cahalan, 1999). The currents were
activated slowly under this condition and reached thestores (Ribeiro et al., 1997); in contrast, CytoD has no
effect on CCE (Ribeiro et al., 1997; Patterson et al., 1999). maximal level in z5 min in the wild-type PS1 cells after
establishment of the whole-cell configuration (FiguresWe examined whether CytoD could abolish the effect
of PS FAD mutations on Ca21 influx (Figures 5C and 5D). 6A and 6B). In contrast, M146L-PS1 cells exhibited se-
verely impaired ICRAC (Figures 6A and 6B). Similar dataCytoD had essentially no effect on Ca21 influx in either
wild-type PS1 or M146L-PS1 cells and had no effect on have been obtained using stable M146L-PS1 SY5Y cell
lines (data not shown). The average current density wasthe reduced CCE phenotype seen in M146L-PS1 cells
(Figure 5D). Similar results were found using N141I-PS2 significantly reduced in M146L-PS1 CHO cells as com-
pared to wild-type cells (Figure 6C). Under our experi-cells (data not shown). FAD-associated presenilin muta-
tions may therefore affect CCE directly and independent mental conditions, pretreatment of cells with SKF96365
of the Ca21 mobilization pathways that require an intact virtually eliminated ICRAC in wild-type PS1 CHO cells (Fig-
cytoskeleton. ure 6C), indicating that ICRAC is sensitive to pretreating
cells with SKF96365.
A novel arachidonate-regulated current (IARC) has beenImpaired ICRAC in M146L-PS1 Cells
reported, and channel properties of IARC appeared to beFunctional activities of putative plasma membrane CCE
similar to that of ICRAC (Shuttleworth, 1996). However, IARCchannels can be detected as calcium release–activated
is activated even after the store depletion (Mignen andCa21 current, also known as store-operated Ca21 current
Shuttleworth, 2000). We tested whether PS1 FAD muta-(ICRAC) (Hoth and Penner, 1992; Zweifach and Lewis,
1993). The effects of presenilin FAD mutations on CCE tion affects IARC after the induction of ICRAC via store deple-
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Figure 6. Impaired Calcium Release–Acti-
vated Calcium Currents (ICRAC) in M146L-PS1
Cells
(A) ICRAC channel activities were measured in
the stable CHO cells expressing either wild-
type (WT) or FAD mutant (M146L) PS1 by the
whole-cell patch clamp experiments. The
currents were activated following dialysis
with 10 mM BAPTA (passive depletion). Mem-
brane potential was held at 0 mV, and hyper-
polarizing voltage pulses at 2120 mV were
applied every 10 s. The transient and leak
currents were not canceled.
(B) Comparison of time courses of the activa-
tion of ICRAC channels in wild-type and M146L
PS1 cells. Inward currents were evoked by
applying hyperpolarizing pulse at 120 mV at
a holding potential of 0 mV. Data points are
the current levels measured every 10 s. The
leak currents were canceled.
(C) Comparison of average peak ICRAC cur-
rent densities (pA/pF) from wild-type (WT)
and M146L-PS1 cells. Wild-type PS1 cells
were also pretreated in parallel with 10 mM
SKF96365 for 30 min before the current mea-
surement (WT 1 SKF96365). The average
peak current density in M1465L-PS1 cells
was significantly smaller than that of wild-
type PS1 cells (n 5 23, *p , 0.05).
(D) Arachidonate-regulated Ca21 currents
(IARC) were preserved in M146L-PS1 cells.
After ICRAC currents reached the stable levels
in 6–7 min, arachidonic acid (8 mM) was
added to induce IARC currents on top of ICRAC
currents. Currents were measured as de-
scribed in (A).
tion. Arachidonic acid–induced currents followed by (Figures 7A and 7B). In contrast, nifedipine and v-cono-
toxin GVIA had no significant effect on Ab42 generationICRAC were preserved in both wild-type and M146L-PS1
cells (Figure 6D). This indicates that presenilin FAD spe- (Figures 7A and 7B). This Ab42-promoting effect of
SKF96365 was dose dependent (Figure 7C) and in-cifically affects the store-dependent current ICRAC but not
store-independent currents such as IARC. versely correlated with relative magnitudes of CCE (Fig-
ure 7D). Under these conditions, SKF96365 treatment
did not alter secreted APP-a levels or cell viability inA CCE Inhibitor, SKF96365, Elevates Ab42 Levels
To gain insight into the molecular link between the PS these cultures (data not shown). Thus, inhibition of the
cellular pathways involving CCE specifically increasesFAD-driven changes in the CCE response and alter-
ations in Ab42 production, we first examined the effect Ab42, which is a molecular phenotype linked to FAD
mutant presenilins.of the CCE antagonist SKF96365 on Ab production using
a sensitive Ab-specific sandwich ELISA (Johnson-Wood
et al., 1997; Xia et al., 1997). SKF96365 decreased both Ab42-Promoting Effect of SKF96365 Requires
Biological Activity of Presenilinsstore depletion–activated Ca21 influx (Figure 5A) and
currents (Figure 6C). Since Ab levels (e.g., Ab42) in SY5Y We next tested whether the Ab42-elevating effect of
SKF96365 requires the biological activity of the prese-cells are not readily detectable, we utilized CHO or 293
cells stably overproducing human APP695. SKF96365 nilins. For this purpose, we treated CHO cells stably
expressing D257A-PS1 with SKF96365 and measuredhas been shown to have a minor inhibitory effect on
voltage-operated Ca21 channels (Merritt et al., 1990; Ma- Ab generation. As previously reported (Wolfe et al.,
1999), total Ab levels were dramatically lower in D257A-son et al., 1993; Grudt et al., 1996); therefore, we in-
cluded nifedipine and v-conotoxin GVIA as negative PS1 cells than in wild-type PS1-expressing CHO cells
(Figure 7E). Ab42 was also reduced in D257A-PS1 cellscontrols to ensure the CCE specificity of SKF96365 on
Ab generation. The concentrations of SKF96365, nifedi- relative to wild-type PS1 cells, but to a lesser extent
than total Ab (Figure 7F). Treatment with SKF96365 didpine, and v-conotoxin GVIA were chosen based on the
previous studies (Grudt et al., 1996; Vazquez et al., 1998; not restore the generation of either total Ab or Ab42
in the D257A-PS1 cells, indicating that the biologicalJayadev et al., 1999). Interestingly, treatment of CHO
or 293 cells stably overexpressing human APP with activity of PS1 is required for the Ab42-promoting effect
of SKF96365. In D257A cells, relative Ab42 levels follow-SKF96365 specifically elevated the ratio of Ab42/Abtotal
Neuron
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Figure 7. Effects of a CCE Inhibitor, SKF96365, on Ab Generation
(A and B) Effects of SKF96365 (100 mM), nifedipine (1 mM), and v-conotoxin GVIA (1 mM) on the ratio of Ab42/Abtotal in CHO (A) or HEK293
(B) cells stably overexpressing human APP (12 hr treatment). Controls were DMSO (solvent) only. Amounts of Ab42 and Abtotal were determined
by sandwich ELISA. The ratios of Ab42/Abtotal from three independent experiments are plotted. Horizontal bars represent average Ab42 to
Abtotal ratios (n 5 12, *p , 0.0001 and **p , 0.0005, respectively, as compared to controls).
(C and D) Correlation of reduced CCE and increases in the Ab42/Abtotal ratio. CHO cells stably expressing human APP were treated with
indicated concentrations of SKF9635 for 12 hr. Relative mean peak amplitudes (D) and corresponding Ab42/Abtotal ratios (C) are shown.
(E and F) CHO cells stably expressing APP and PS1 variants (either PS1 wild-type [WT] or D257A-PS1 [D257A]) were incubated in the absence
(2) or presence (1) of 50 mM SKF96365. Columns represents relative amounts of total Ab (E) or Ab42 (F) in the culture media. All values were
normalized to total protein amounts in the cell lysates.
ing treatment with SKF96365 was greater than 90% of effect on CCE (Figure 8A). Furthermore, pretreatment of
the cells with Ab42 also had no detectable effect on thetotal Ab levels (Figures 7E and 7F). Under identical con-
ditions (50 mM SKF96365, 12 hr), the degree of CCE CCE response (Figure 8A versus Figure 8B). Cell viability
was not affected under these conditions, and similarreduction in D257A-PS1 cells was much less compared
to wild-type PS1 cells’ reduction (data not shown). data have been obtained using 293 and SY5Y cell lines
(data not shown). Therefore, the reduced CCE in FAD
mutant presenilin cells is not likely to be due to increasedElevated APP or Ab42 Do Not Alter CCE
extracellular or intracellular levels of Ab42.We next tested whether CCE reduction by FAD-linked
presenilin mutations might be due to the increased ac-
cumulation of Ab42. Utilizing CHO-APP cells that pro- Discussion
duce substantially elevated levels of APP and Ab42 (Xia
et al., 1997), we found that stable overproduction of APP The presence of biologically active PS1 or PS2 is essen-
tial for the generation of Ab through g-secretase cleav-(and the subsequent increase in Ab42) had virtually no
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to other molecular phenotypes associated with FAD mu-
tant presenilins, including altered unfolded protein re-
sponse (Katayama et al., 1999; Niwa et al., 1999) and
increased vulnerability to apoptotic stimuli (Deng et al.,
1996; Wolozin et al., 1996; Janicki and Monteiro, 1997).
Interestingly, in transgenic mice harboring spinocere-
bellar ataxia type 1 (SCA1) mutant gene products, TRP3,
SERCA2, and IP3-R, all components of CCE, were specif-
ically downregulated. This suggests the potential contri-
bution of CCE dysregulation in other neurodegenerative
diseases in addition to AD (Lin et al., 2000). CCE involves
direct physical interaction between the ER and plasma
membrane constituents (reviewed by Putney, 1999a;
Berridge et al., 2000). According to this conformational
coupling mechanism, a conformational change of the
IP3 receptor (IP3-R) upon agonist stimulation and subse-
quent release of Ca21 leads to the formation of a molecu-
lar complex containing IP3-R bound to molecular constit-
uents in the plasma membrane harboring CCE channels.
This then allows extracellular Ca21 to replenish the ER
store (Kiselyov et al., 1998, 1999; Boulay et al., 1999;
Putney, 1999a). It has been postulated that the prese-
nilins modulate the g-secretase activity via few possible
mechanisms: the presenilins might be the g-secretases
themselves, serve as essential cofactors for the g-secre-
tase action, or regulate intracellular trafficking of a puta-
Figure 8. Elevated APP or Ab42 Levels Confer No Effects on CCE tive g-secretase to the target site where relevant sub-
Effect of stable overexpression of human APP (A) and Ab42 pretreat- strates are localized (De Strooper et al., 1998; Naruse
ment (B) on the CCE response in CHO cells.
et al., 1998; Wolfe et al., 1999; reviewed by Selkoe, 2000).(A) CCE was assayed by ratiometric Ca21 imaging using either native
Given a role for presenilins in governing CCE, the pre-CHO cells (CHO) or CHO cells stably overexpressing human APP695
senilins may also modulate proteolytic processing of(CHO-APP).
(B) CHO and CHO-APP cells were preincubated with 20 mM Ab42 APP and Notch at or near the cell surface (Annaert and
for 3 hr prior to induction of CCE (compare to [A]). Data points are De Strooper, 1999) at sites of ER–plasma membrane
mean fluorescence ratios 6 SEM in 33 cells. coupling. It is conceivable that the presenilins may regu-
late or directly mediate the cleavage of protein(s) in-
volved in modulating CCE. In any event, a gain in the
age of APP (De Strooper et al., 1998). Our current studies biological activity of the presenilins, owing to autosomal
demonstrated that abrogation of biological activities of dominant FAD mutations, may attenuate CCE while in-
PS1, by either knocking out PS1 or expressing inactive creasing g-secretase activity. Further experimentation
PS1 mutants, greatly potentiated CCE, suggesting that will be necessary to elucidate this connection. Finally,
a normal function of PS1 (and perhaps PS2) is to modu- augmentation of CCE, through the identification of ago-
late CCE. We also showed that treating cells with a nists of plasma membrane store–operated Ca21 chan-
CCE inhibitor (SKF96365) downregulates CCE and ICRAC nels (e.g., TRP or as yet undiscovered CCE channels)
and selectively elevates Ab42 generation. However, in- that mediate CCE (Birnbaumer et al., 1996; Zhu et al.,
creased cellular levels of Ab42 had no effect on CCE, 1996; Li et al., 1999; Putney, 1999b; Philipp et al., 2000),
suggesting that reduced CCE might be an early cellular could potentially be employed to reduce PS-associated
event leading to the increased Ab42 generation associ- g-secretase activity, and the generation of Ab as a novel
ated with presenilin FAD mutations. Interestingly, pre- therapeutic means for preventing or treating AD.
liminary data revealed that direct inhibition of Ab genera-
tion using a synthetic g-secretase inhibitor displayed no
Experimental Procedureseffects on CCE, further supporting the idea that prese-
nilin-mediated modulation of CCE is an upstream event
Cell Culture, Generation of Stable Cell Lines, and Ab Treatmentof Ab generation (T.-W. K., unpublished data).
Stable PS1 SY5Y cell lines were generated by transfecting 0.5 mg
According to our model, autosomal dominant FAD of pBabe along with 5 mg of each plasmid: PS1, M146L-PS1, D257A-
mutant presenilins exert a gain of function by downregu- PS1, or vector alone (pcDNA3.1) using Superfect transfection re-
lating CCE while increasing IP3-mediated release from agent (Qiagen). Individual puromycin-resistant colonies were iso-
lated and screened for PS1 expression by Western blotting. Stablethe ER store, leading to diminished luminal Ca21 concen-
PS1 SY5Y cell lines were maintained in DMEM supplemented withtration ([Ca21]ER) (Waldron et al., 1997; Hofer et al., 1998).
10% fetal calf serum and penicillin/streptomycin in the presence ofIt is interesting to note that changes in [Ca21]ER influence
1 mg/ml puromycin (Sigma) at 378C in 5% CO2 incubator. Othera number of cellular functions, including chaperone ac-
stable cell lines, including PS2 SY5Y cells (Pack-Chung et al., 2000)
tivities and gene expression (reviewed by Meldolesi and and PS1 CHO cells (Wolfe et al., 1999), have previously been de-
Pozzan, 1998). Therefore, it is tempting to speculate that scribed. The Ab42 peptides were obtained from Bachem and dis-
solved in PBS at 1 mg/ml directly before use.reduced CCE may also be an upstream event leading
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Western Blot Analysis and Immunoprecipitation transferred to HBSS dissociation media. The dissociation media
contains 13 HBSS (Gibco, Grand Island, NY), 15 mM HEPES, 7.5%Western blot and immunoprecipitation analyses were performed as
previously described (Pack-Chung et al., 2000). Brain tissues from sodium bicarbonate, and 2.47 g/0.5 L glucose (pH 7.4). The tails are
harvested for DNA extraction and PCR analysis of genotype. Thethe transgenic animals were homogenized in solution A (0.32 M
sucrose, 1 mM MgCl2, 0.5 mM CaCl2, 1 mM NaHCO3) containing brain is dissected out of the head with forceps, and the pia and
connective tissue are carefully removed. After dissection is com-protease inhibitors using a motor-operated Teflon glass homoge-
nizer. The resulting tissue homogenate was lysed using IP buffer plete, brains are washed with fresh HBSS dissociation media, and
the tissue is transferred to a 15 ml falcon tube containing 1 ml trypsin(10 mM Tris-HCl [pH 7.4], 150 mM NaCl, 1% Triton X-100, 0.25% NP-
40, 2 mM EDTA) and subjected to immunoprecipitation, SDS–PAGE, and 0.001% DNase. Tubes are placed in a 378C water bath for 10–12
min and are shaken every 2–3 min to break the clump of tissues.and Western blot analysis. To detect secreted APP produced from
the a-secretase-mediated cleavage of APP (APPs-a), media col- Neurobasal media (1.5 ml) with 10% serum is added to each of the
tubes. Cell are mildly dissociated using a polished Pasteur pipette.lected from the abovementioned samples of 293 cells were immuno-
precipitated by antibody 22C11 and blotted with antibody 6E10. Tissues are allowed to settle at room temperature for 4–6 min. The
supernatant is removed and spun for 5 min at room temperature at
1000 rpm, and pellets are resuspended in 2 ml neurobasal mediaCalcium Imaging
with serum. Cells are counted and plated at a density of 40,000Briefly, cells are grown on 25 mm round glass coverslips for at least
cells/cm2. Cells are plated onto 25 mm coverslips coated with poly-24 hr before measuring [Ca21]i. Fura-2 acetoxymethyl ester (fura-2/
L-lysine (0.25 mg/ml). After 2 hr, media are removed and replacedAM) is dissolved in DMSO and further solubilized in Pluronic acid
with neurobasal media supplemented with B27, glutamine, and Pen/(0.08%), in HBSS (145 mM NaCl, 2.5 mM KCl, 1 mM MgCl2, 20 mM
Strep.HEPES, 10 mM glucose, and 1.8 mM CaCl2) containing BSA (1%).
When Ca21-free medium is used, Ca21 is replaced with 50 mM EGTA.
Fura-2/AM is loaded into cells by incubation with HBSS containing Quantitation of Ab Using Sandwich ELISA
fura-2/AM (5 mM) at 378C for 30 min. Fluorescence emission at 505 Ab sandwich ELISA was performed as previously described (John-
nm is monitored at 258C using a dual wavelength spectrofluorometer son-Wood et al., 1997). Ab266 (to Ab residues 13–28) and 21F12 (to
system with excitation at 340 and 380 nm. Ratios (fluorescence Ab residues 33–42) were used as capture antibodies for Abtotal and
intensity at 340 nm/380 nm) are obtained from 8-frame averages of Ab42, respectively. Biotinylated 3D6 (to Ab residues 1–5) was used
pixel intensities at each of the excitation wavelengths. Statistical as the reporter antibody for both Abtotal and Ab42 assays.
analyses were performed by two-tailed unpaired t test using InStat
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